Close Menu

NEW YORK ─ Kantaro Biosciences and EKF Diagnostics have inked a two-year agreement to distribute and market two SARS-CoV-2 IgG antibody test kits, Kantaro said on Wednesday.

Under the terms of the agreement, EKF will market and distribute Kantaro's quantitative SARS-CoV-2 IgG antibody test kit, called COVID-SeroKlir, in Europe and have exclusive rights in the UK and Germany. Further, Cardiff, Wales-based EKF will market and distribute a second Kantaro quantitative SARS-CoV-2 IgG antibody test kit, COVID-SeroIndex, for the European research market on a non-exclusive basis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.